Mobile Apps Enhancing Acupressure Therapy Compliance and Efficacy for Asthenopia

The Role Of Mobile Applications In Therapy Compliance And Efficacy Of Acupressure In Asthenopia

The goal of this clinical trial is to learn if a mobile application works to improve adherence to acupressure therapy in asthenopia. It will also learn about the efficacy of acupressure as a therapy for asthenopia. The main questions it aims to answer are:

-Does a mobile application have a role to improve therapy compliance and efficacy of self-guided acupressure in asthenopia?

Researchers will compare users of a mobile app to non-users of a mobile app to see if a mobile app works to improve adherence to acupressure therapy in asthenopia

Participants will:

• Do acupressure 2 times every day for 4 weeks
• Filling in the absence link has been after doing acupressure every day
• Fill out the link regarding the condition of asthenopia once per week

Study Overview

• Status: Not yet recruiting
• Conditions: Asthenopia
• Intervention / Treatment: Procedure: Acupressure

Detailed Description

This is a clinical trial study to evaluate the role of a mobile application in therapy compliance and acupressure efficacy in asthenopia sufferers. Participants are 60 males/females aged 18-64 years. They will be divided into 2 groups: (1) Acupressure mobile app users and (2) Non-acupressure mobile app users. Acupressure is scheduled 2 times every day for 4 weeks. Therapy compliance will be assessed from the absence link that participants fill out every day, while therapy efficacy will be assessed once per week for 4 weeks.

• Study Type: Interventional
• Enrollment (Estimated): 60
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Dion Rukmindar, MD; Phone Number: +6285217264132; Email: dion.rukmindar@ui.ac.id

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Using a smartphone with the Android platform.
• Work or use digital gadgets for at least 4 hours a day.
• Suffering from asthenopia as indicated by a CVS-Q score ≥ 6.
• Can be contacted with the WhatsApp application.
• Willing to take part in this research until completion and agree to informed consent.

Exclusion Criteria:

• There are tumors, wounds or skin infections in the eye area.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Non-Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Mobile app users; Mobile application users will be notified twice per day to perform acupressure. Instructions for performing acupressure are in the mobile app	Procedure: Acupressure; Acupressure is a technique that involves applying pressure to specific points on the body. It is based on the same principles as acupuncture but uses pressure from fingers, palms, elbows, or specialized devices instead of needles.
Active Comparator: Not a mobile app user; Non-users of the mobile application will be given an explanation of how to perform acupressure at the start of the study and will not be reminded to perform acupressure therapy.	Procedure: Acupressure; Acupressure is a technique that involves applying pressure to specific points on the body. It is based on the same principles as acupuncture but uses pressure from fingers, palms, elbows, or specialized devices instead of needles.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Daily Report of Acupressure	Daily acupressure reports are used to monitor participants' therapeutic compliance in performing acupressure every day	2 times every day for 4 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Computer Vision Syndrome Questionnaire (CVS-Q)	The Computer Vision Syndrome Questionnaire (CVS-Q) is a tool used to assess symptoms related to prolonged computer use or other digital screens. It typically consists of a series of questions designed to evaluate various discomforts experienced by individuals who spend significant time in front of screens. These questions may inquire about symptoms such as eye strain, headaches, blurred vision, dry eyes, neck or shoulder pain, and general fatigue. A CVS-Q score ≥ 6 indicates asthenopia	Monitored once per week for 4 weeks
Visual Analog Scale (VAS)	VAS is used to assess complaints of asthenopia intensity on a scale of 1-10	Monitored once per week for 4 weeks

Collaborators and Investigators

• Sponsor: Indonesia University
• Investigators: Principal Investigator: KEPK FKUI-RSCM, The Ethics Committee of the Faculty of Medicine, University of Indonesia - RSCM

Study record dates

Study Major Dates

• Study Start (Estimated): June 1, 2024
• Primary Completion (Estimated): July 1, 2024
• Study Completion (Estimated): July 1, 2024

Study Registration Dates

• First Submitted: May 12, 2024
• First Submitted That Met QC Criteria: May 16, 2024
• First Posted (Actual): May 17, 2024

Study Record Updates

• Last Update Posted (Estimated): June 4, 2024
• Last Update Submitted That Met QC Criteria: June 1, 2024
• Last Verified: June 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Eye Diseases; Asthenopia
• Other Study ID Numbers: 24-03-0424

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No